+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
Neutropenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Neutropenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 323 Pages
  • Global
From
From
From
From
From
Rheumatoid Arthritis - Epidemiology Forecast to 2029 - Product Thumbnail Image

Rheumatoid Arthritis - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 46 Pages
  • Global
From
Crohn's Disease - Epidemiology Forecast to 2029 - Product Thumbnail Image

Crohn's Disease - Epidemiology Forecast to 2029

  • Report
  • September 2020
  • 47 Pages
  • Global
From
From
From
From
Alopecia Areata: Epidemiology Forecast to 2028 - Product Thumbnail Image

Alopecia Areata: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 31 Pages
  • Global
From
From
From
US Alopecia Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Alopecia Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Celiac Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Celiac Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Myelofibrosis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Myelofibrosis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Crohn's Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Crohn's Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more